Tag: biosimilar
Biocon Sees 3.10% Jump After Securing U.S. Deal for Yesafili Biosimilar—Is This a Game Changer?
Biocon, a global leader in biopharmaceuticals, is making waves in the ophthalmology field with the launch of Yesafili,…
Biocon FDA Approval JOBEVNE Biosimilar Could Rewrite Cancer Care Costs
Biocon FDA Approval for JOBEVNE Biosimilar Marks a Big Win in Cancer Care Biocon Biologics has received U.S.…